International Journal of Nephrology / 2017 / Article / Tab 1

Clinical Study

Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study

Table 1

Baseline characteristics of the patients.

DenosumabControl value

Age (years)72.8 ± 9.571.2 ± 11.0NS
Body mass index (kg/m2)21.6 ± 2.320.8 ± 2.3NS
HD duration (years)7.1 ± 4.96.4 ± 5.3NS
BMD (% of young mean)56.7 ± 7.254.7 ± 11.0NS

Continuous values are given as mean ± SD. The body mass index is the weight in kilograms divided by the square of the height in meters. BMD: bone mineral density; NS: not significant.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.